INTRODUCTION
Although major advances in the care of patients with malignant cancers over the past several decades have resulted in improved survival, infections remain a significant cause of morbidity and 1 mortality . These Patients are immunocompromised because of both the malignancy and the treatment 2 used to manage it . This renders them susceptible to 3 bacterial and fungal infections . Early diagnosis is difficult, because a severe infection may be 3 asymptomatic or only manifests as fever or malaise . Therefore, treatment for these infections is empirical, and broad-spectrum antibiotics are 4 recommended for patients presenting with fever .
Recently advances in effective Chemotherapy drugs and regimens that have improved survival rates of these patients. In spite of the obvious improvements, chemotherapy still has certain disadvantages; it induces the breakdown of mucosal barriers, usually leading to high risk of neutropenic fever, which is associated with development of severe infection and high mortality. Thus, early initiation of 5 antimicrobial therapy is vital in the management of haematological cancer patients receiving intensive chemotherapy.
Bacteraemia may cause serious complications if left untreated, while treating viral illnesses or noninfective causes of in? ammation with antibiotics is not only ineffective, but also contributes to the development of resistance, increases costs, and the 6 risks of toxicity and hypersensitivity reactions hence, the need to find indicators of bacterial infection to allow for early commencement of treatment.
Procalcitonin (PCT) is a 116 amino acid precursor of the hormone calcitonin. It has been shown, that bacterial infections are capable of triggering ubiquitous expression of the calcitonin gene(CALC-1), along with constitutive release of PCT from a number of tissues and differentiated cell types, so that a significant increase of PCT levels can be observed in patients with severe bacterial 9 infection and/or sepsis .
C -reactive protein (CRP) is an acute-phase protein that is synthesized in the liver in response to interleukin 6 and is normally found at concentrations of less than 10 mg/L in the blood. During infectious or inflammatory disease states, CRP levels rise rapidly and its levels are frequently used to aid 10 diagnosis of infections . This study aimed at evaluating the value of PCT and CRP, in early diagnosis of bacterial infections in patients with haematological malignancies on chemotherapy.
METHODS

Study area and population
The study was conducted at the University Teaching Hospital (UTH) and Cancer Diseases Hospital (CDH) Lusaka, Zambia from February to July, 2016. Our study population included Patients with a h a e m a t o l o g i c a l m a l i g n a n c y r e c e i v i n g chemotherapy whether presenting with fever or not. Patients between the ages of 3 to 70 years were recruited. Paediatric patientsseen from the paediatric oncology ward were included in the study, while adult patients were recruited from the Department of Medicine at the University Teaching Hospital. Other adult patients those with lymphomas were seen within the various wards of the Cancer Diseases Hospital.This study was approved by the Zambia Biomedical Research Ethics Committee.
Study design, algorithm and data collection
This was a cross sectional study involving sixty eight(68) patients. Patients were evaluated for clinical evidence of infection, and samples collected for processing. Prior to specimen collection the body temperature was taken and recorded by an attending nurse or clinician. Fever was defined as a sustained single oral temperature reading higher than 38.0°C. Neutropenia was defined as leukocyte count less than 1.0×109/L for adults and 1.5×109/L for paediatric patients. Patients referred to as "with bacteraemia" were those with a positive blood culture while "patients without bacteraemia" were those with no bacteriological or clinical signs of infection, and did not receive antibiotics for at least one month.
Figure 1:
shows the process that was followed from participant recruitment, to specimen collection and processing Demographic and clinical data were collected from patients and their files. The medical history data included the specific type of malignancy a patient has, whether or not they were chemotherapy, any other medication they had taken and the presence of medical conditions that may confound the research findings; included here were any major surgeries, burns, myocardial infarction and so on.
Specimen collection
Blood cultures were collected first using a 10 ml 21G syringe for adults and a 5 ml syringe for children. About 8mls of adult blood was then transferred into the blood culture bottle for adults and 1 to 3ml of blood into the paediatric blood culture bottles. The remaining 2mls of blood was transferred into plain containers and labelled appropriately. The blood specimens were transported to the laboratory within 1 hour after collection for preparation and storage. Blood culture bottles were incubated in the BACTEC™ FX blood culture system immediately upon arrival in the laboratory.
Before collection of blood, the skin was cleaned vigorously over the veni-puncture site in a circle approximately 5cm in diameter with an alcohol swab for about 30 seconds. Starting from the centre of the circle, 10% povidine iodine (betadine) was applied in ever widening circle until the entire circle was saturated with iodine, then left to dry for about 30 to 40 seconds. When collection was complete the iodine was removed from the skin with an alcohol swab. The cap was then removed and the septum disinfected with an alcohol swab and allowed to air dry.
Specimen analysis
The Human procalcitonin and C-reactive protein ELISA (Enzyme-Linked Immuno-sorbent Assay), a quantitative competitive immunoassay was used for measurement of PCT and CRP. It's manufactured and supplied by Neo-scientific group, United States of America. For bacteriological analysis specimens were incubated in the BACTEC™ FX blood culture system and Subculture unto Blood Agar, Chocolate Agar and Mac Conkey Agar and used the VITEK system for identification of microorganisms and their species.
Statistical analysis
Data was analysed with Statistical Package for Social Sciences (SPSS) version 21 and STATA version 12, results were summarised on to tables and graphs. All statistical tests were performed at 5% significance level or 95% confidence interval with p-value of less than 0.05 to determine statistical significance. Patients were grouped as blood culture positive (bacteraemia group) and blood culture negative (non-bacteraemia group) then compared with demographic and clinical characteristics as well as the levels of PCT and CRP in both groups. Descriptive statistics were reported in terms of absolute frequencies and percentages. Distributions of CRP data were described in terms of median values and range, because of its non-normal distribution. Comparison between groups was performed using the nonparametric Mann-Whitney U test for CRP. Procalcitonin values were normally distributed and were described in terms of mean values. Comparisons between groups were performed using an independent t-test. Data was calculated for sensitivity and specificity, derived f r o m r e c e i v e r o p e r a t i n g characteristics (ROC) curve with blood culture as a reference. Performance indicators of PCT and CRP for various cut-off values were also analysed.
RESULTS
Study participant characteristics
As shown in table 1, a total of 68 participants were enrolled in the study, of which 36 (52.9%) were males and 32 (47.1%) were females.The median (range) age was 14 (4-43) years in the group with bacteraemia and 16 (4-70)in the group without bacteraemia. Twenty two (22) of the participants presented with fever and neutropenia while 46 of them only had neutropenia. Bacteraemia was detected in 14 (20.6%) of the 68 patients using blood culture. All patients were suffering from a haematological malignancy and were receiving chemotherapy. Amongst the diagnoses were acute leukaemia (26.5%), Chronic leukaemia (16.2%), Hodgkin's Lymphoma (13.2%), Non-Hodgkin Lymphoma (36.8%), Multiple myeloma (4.4%), Langerhan histiocytosis (2.9%). (14) blood cultures were positive out of the total sixty eight (68) patients enrolled in the study among patients with haematological malignancies and gram-positive organisms were the most frequent isolated agents responsible for 71% (10) of positive cultures, with gram-negative representing 29% (4). The most frequent microbial agents isolated were staphylococcus spp, bacillus spp, Corynebacteria spp and E.coli As shown in the table above, all characteristics were not associated with bacteraemia except for PCT levels and presence of fever. As shown in figure 02, the median CRP concentrations for the bacteraemia group and nonbacteraemia group being 23. As shown in figure 03 , the mean PCT concentrations for the group with bacteraemia and those without were 6.1 ± 1.3ng/ml and 5.1 ± 1.7ng/ml respectively. The bacteraemia group had higher mean PCT levels than those without bacteraemia (p=0.023).
The distribution of PCT and CRP level between groups
Area under ROC curve for PCT and CRP
ROC Curves were used to determine the diagnostic value of using CRP and PCT to predict an infection in patients with haematological malignancies. As shown in table 2 below, the area under curve (AUCs) was 0.702 (95% CI =0.35 -0.69) for PCT and 0.519 (95% CI=0.57 -0.84) for CRP. Area under curves values for each marker PCT (0.702) demonstrate greater discriminatory ability than CRP (0.52) to differentiate infections, suggesting that PCT is superior to CRP in detecting bacteraemia. The results also showed that the AUC for PCT (0.702) was statistically significant in discriminating bacteraemia (p=0.021), compared with CRP (p=0.832) 
Figure 4: Receiver operating characteristic curves for procalcitonin and C-reactive protein levels
and the Confidence intervals (CI).
As can be seen from the table, the AUC for PCT (p=0.021) was significant compared with CRP in predicting a bacterial infection.
Performance indicators at different Cut-off values
From Table 3 , Cut offs for PCT that we used were 4.7ng/ml, 5.0ng/ml, 5.1ng/ml. These cut-off values were chosen based on the best sensitivity and specificity obtained from ROC curve analysis and according to the literature. The cut offs for CRP were not satisfactory as both the sensitivity and specificity were low but a cut off of 21mg/ml gave us the sensitivity and specificity of 64% and 44% respectively. 
Correlations of PCT and CRP in patients with haematological malignancies
There was a positive correlation between levels of PCT and CRP, as can be seen in figure 05, in both groups with and without bacteraemia. This shows a close relationship between the two biomarkers. Spearman Correlation Coefficient indicated statistical significance r = 0.39 (p < 0.001).
Figure 5: Correlation between the serum concentrations of C-reactive protein (CRP) and procalcitonin (PCT)
Bacterial infections isolated
Fourteen (14) As can be seen from the table, a higher distribution of gram positive bacteria has been noted in this study.
DISCUSSION
The value of the inflammatory biomarkers such as PCT and CRP, in the diagnosis and assessment of infection in non-neutropenic patients has been well established in clinical studies during the past 14 decade . Although it has been shown that PCT can 15 16 also be produced by leukocytes , Carnino et al reported that PCT and CRP react more, in deeply neutropenic patients their study done in Italy.
Ruokonen, Sauer and Kim in their separate studies involving immunocompromised patients recently demonstrated that these patients are also capable of producing high PCT serum levels in severe systemic [17] [18] [19] bacterial or fungal infections . Our results in which PCT levels were elevated in patients with bacteraemia in patients with neutropenia support these findings, despite there are concerns that these markers may be produced in low concentration in 20 patients with neutropenia .
In our study PCT levels increased significantly in the presence of bacteraemia. The mean PCT levels were 
Staphylococcus aureus 02
Corynebacteria jeikeium 02
Bacillus spp 02
Gram Negative Bacteria (GNB)
Klebsiela pneumonia 01
Escherichia coli 02
Enterobacter cloacae 01
TOTAL 14
statistically different in patients with bacteraemia and the group (p=0.023), with PCT being more elevated among patients with bacteraemia. This was not observed with CRP levels between the two groups as there was no significant differences between the two groups (p=0.832). These findings were similar to a study done by Marshal et al, where they found that PCT levels were higher (p< 0.01) in 21 bacteraemia but CRP showed no statistical significance (p=0.79) among HIV patients.
In this study the area under ROC curve for PCT was found to be 0.702 in contrast to 0.519 for CRP for discriminating between patients with bacteraemia and those without bacteraemia. It can be seen from these findings that CRP had poor discriminatory power and hence cannot be reliably used as a diagnostic marker of bacteraemia in patients with h a e m a t o l o g i c a l m a l i g n a n c i e s r e c e i v i n g chemotherapy. In contrast PCT performed well in discriminating bacteraemia in these patients.
The cut offs for CRP were not satisfactory as both the sensitivity and specificity were low. The best cut off for PCT was 4.7ng/ml which corresponds to the sensitivity and specificity of 86% and 54% respectively with relatively favourable likelihood ratios as compared to other cut off values. In the clinical and Laboratory sense, these results imply that PCT is a marker that might help clinicians to detect bacteraemia early in patients with haematological malignancies on chemotherapy. A similar cut off for PCT reported in our study was also by suggested by Massaro et al where they reported that PCT concentrations of between 1ng/ml to 17 5ng/mL were strongly suggestive of bacteraemia . However, PCT is better at detecting bacteria in blood but not necessarily its absence, since the specificity is not high enough. Therefore, we suggest that the use of this marker should always be followed up with standard microbiological analysis.
The characteristics of CRP, such as its insufficient specificity, and vulnerability to immunosuppressant, are probably reflected by these results. other causes of infections or inflammation This probably explains the superiority of PCT compared to CRP, in the diagnosis of bacteraemia which has been demonstrated in our study.
We further explored the relationship between PCT and CRP and found that there was positive correlation(r=0.39, p<0.001). These findings indicate a linkbetween the two markers. That is, the variations in PCT concentration were concomitant with the variations in CRP concentrations. Further, studies are required to determine the value of constructing combinations between PCT and CRP, this might give a higher diagnostic value than examine them individually.
From studies by Gencer, Perola and Rintalareported the incidence of bloodstream bacterial infections of between 7.7% and 37% in [19] [20] [21] patients with neutropenic fever . In this study we found the prevalence of bacterial infection in patient with haematological malignancies with neutropenia to be 20.6% (14) out of 68 patients.
In our study, Gram positive bacteria were the most commonly isolated organisms in comparison to Gram negative bacteria. This finding was in line with a study by Ramphal that indicated a shift in the cause of bacteraemia in cancer patients from predominance of gram-negative rods to gram- 22 positive cocci . The most common infective agent that we isolated is Coagulase-negative staphylococci, mainly Staphylococcus epidermidis increase in gram positive organisms have not been clearly identified but this could suggest; indwelling intravascular devices, high dose chemotherapy inducing mucositis, more importantly prolonged 2, 22, 23 neutropenia . There is inherent risk of infection that some low-virulence gram positive organisms 24 pose in immunocompromised patients .
Although, a shift in favour of gram positive organisms infection has been noted among patients with neutropenia, gram negative organisms are still 23 important and are associated with high mortality .
CONCLUSION
Procalcitonin was a more reliable and sensitive marker of bacteraemia than CRP. Its measurement could be useful in the early diagnosis of bacterial infections in these patients. In contrast, the sensitivity and specificity for CRP are too low to safely rely on it as a marker of bacteraemia in patients with haematological malignancy; this is in spite of CRP being used routinely in clinical practice as an indicator of bacterial infections.
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